Updated
Updated · spacedaily.com · Jul 4
King’s College London Identifies 74 Anxiety Gene Loci in 693,869 People
Updated
Updated · spacedaily.com · Jul 4

King’s College London Identifies 74 Anxiety Gene Loci in 693,869 People

1 articles · Updated · spacedaily.com · Jul 4

Summary

  • Researchers found 74 genome locations linked to anxiety symptoms — including 39 not previously tied to the condition — in what they describe as the most detailed genetic map of anxiety yet.
  • Data from 693,869 people of European ancestry and a focus on symptom severity rather than yes-or-no diagnoses helped uncover signals that earlier studies missed, roughly doubling prior findings.
  • PCLO and SORCS3 showed especially strong support, and many loci clustered near brain-expressed genes involved in synaptic signaling; the study also found shared genetic risk with heart disease, gut disorders and migraine.
  • Common genetic variation explained about 6% of differences in anxiety severity, while polygenic scores explained up to 2.9%, leaving the findings far from clinically predictive for individuals.
  • With anxiety affecting 359 million people in 2021 and projected to top 515 million by 2040, the map offers new biological targets for drug research rather than an immediate diagnostic test.

Insights

With a new genetic map and novel drugs arriving in 2026, is personalized anxiety treatment finally within reach?
Genetics explain just 6% of anxiety. So what is truly driving the modern anxiety epidemic?
Genes link anxiety to gut and heart disease. What does this mean for treating the mind and body together?

Unveiling 58 Genetic Loci for Anxiety: The Genetic Architecture, Shared Risks, and Future of Precision Psychiatry

Overview

A groundbreaking 2026 genome-wide association study identified 58 genetic loci linked to anxiety disorders, marking a major advance in understanding their complex genetic architecture. The study revealed that many of these genetic signals are enriched in GABAergic pathways, highlighting the central role of GABAergic signaling in anxiety risk. This pivotal insight suggests that dysregulation in these systems contributes to the development of anxiety disorders. These discoveries lay a strong foundation for future research, opening new avenues for targeted therapies and drug development, and guiding scientists toward uncovering the specific molecular mechanisms behind anxiety.

...